Pulmatrix, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Framingham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Pulmatrix, Inc. has filed 630 SEC EDGAR filings since 24 May 2013

SEC filing history

Showing 301-325 of 630 matching filings.

Per page
25
Current page
13
CORRESP

CORRESP filing

Filing date
08 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-230395

424B4

Filing date
05 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36199

8-K

Filing date
04 Apr 2019
Reporting date
03 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-230395

EFFECT filing

Filing date
03 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-230714

S-1MEF

Filing date
03 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-230670

S-1

Filing date
01 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-230395

S-1/A

Filing date
01 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36199

8-K

Filing date
01 Apr 2019
Reporting date
01 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
25 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88056

ARCH VENTURE FUND VII, L.P. - SCHEDULE 13D/A - AMENDMENT NO. 4

Filing date
22 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-230395

S-1

Filing date
19 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-230225

EFFECT filing

Filing date
15 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
14 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-230225

S-3

Filing date
12 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36199

8-K

Filing date
22 Feb 2019
Reporting date
19 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88056

SCHEDULE 13G

Filing date
19 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36199

FORM 8-K

Filing date
19 Feb 2019
Reporting date
19 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-332822

D filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-332821

D filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-332820

D filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88056

PULMATRIX, INC.

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .